What Is Orforglipron? The First Oral GLP-1 Pill for Weight Loss
Orforglipron, sold under the brand name Foundayo, is a once-daily GLP-1 pill for weight loss from Eli Lilly, and it reached a milestone in…
CagriSema vs Zepbound: What the Trial Data Suggests
CagriSema and Zepbound are two of the most powerful weight-loss approaches in obesity medicine, and on trial data they land in a broadly similar…
What Is CagriSema? Cagrilintide and Semaglutide Explained
CagriSema is an investigational once-weekly injectable from Novo Nordisk that combines two different weight-loss ingredients in one shot: cagrilintide, an amylin analog, and semaglutide,…
When Will Retatrutide Be Available? Timeline and What to Expect
If you’re waiting on retatrutide, here’s the realistic answer: it isn’t available yet, and based on Eli Lilly’s published trial timeline, an FDA submission…
Retatrutide vs Ozempic: How the Triple Agonist Stacks Up Against Semaglutide
Retatrutide and Ozempic represent two different generations of obesity and metabolic medicine, and the headline difference is straightforward: in trials, retatrutide has produced substantially…
What Is Retatrutide? The Triple-Agonist Obesity Drug Explained
Retatrutide is an investigational once-weekly injectable being developed by Eli Lilly for obesity, and in clinical trials it has produced the largest weight loss…
The Hormone Behind “Ozempic Vulva”: How Fat Loss Shifts Estrogen
Most of the “Ozempic vulva” conversation focuses on fat leaving the genital area, and that’s the biggest driver, but there’s a hormonal layer underneath…
Caring for Vaginal and Vulvar Health During Rapid Weight Loss
Rapid weight loss on a GLP-1 medication affects your whole body, including intimate tissue, so a little proactive care goes a long way toward…
Painful Sex on GLP-1 Medications: Causes and What Actually Helps
Painful sex during GLP-1 treatment is not something you have to live with, and it usually traces back to a handful of manageable causes….
